Invoke Bio wins $100K QB3 mentoring award for precision cancer vaccines

Biotech startup Invoke Bio won a $100K proof-of-concept award from QB3 after pitching its technology at Bakar Bio Labs on Thursday, June 11, 2026. The live pitch session included founders from six companies selected from the QB3 mentoring program, which helps scientific entrepreneurs shape their companies for investment.

The CEO of Invoke Bio is BISB Ph.D. alumnus Dr. TJ Sears.

Full story